Phase 2 Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 75 years old
- People with a good general health and activity level (rated 0 or 1 on a standard medical scale called the ECOG scale, meaning largely able to carry out normal daily activities)
- People whose doctors expect them to live for at least 12 weeks
- People whose pancreatic cancer has been confirmed through a laboratory test of tissue or cell samples
- People who have not had any cancer treatment before joining this trial
- People whose blood counts meet specific levels when tested within 7 days before starting treatment: enough white blood cells, red blood cells, and platelets (confirm exact levels with trial site)
- People whose liver and kidney function blood tests fall within acceptable ranges when tested before starting treatment (confirm exact levels with trial site)
- People of reproductive age who are willing to use effective contraception during the trial (this applies to both female participants and female partners of male participants)
- People who are willing to voluntarily sign a consent form agreeing to take part in the study
- People who are expected to follow the trial's schedule for check-ups and reporting of side effects
Who may not be able to join:
- People who have already received any systemic cancer treatment
- Women who are pregnant or breastfeeding, or women of childbearing age who do not have a negative pregnancy test result taken within 7 days before enrolling
- People with substance use issues, or personal, psychological, or social circumstances that may make it difficult to give proper informed consent or to participate reliably in the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: du juan, M.D., The Affiliated Hospital of Nanjing University Medical School
Phone: 83106666
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of CIM
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.